MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/rap/rkab037

Медицинская библиотека · Rheumatology advances in practice · 2021

The treatment of Merkel cell carcinoma with immune checkpoint inhibitors: implications for patients with rheumatoid arthritis.

Klee Gina, Kisch Tobias, Kümpers Christiane, Perner Sven, Schinke Susanne, Zillikens Detlef, Langan Ewan A, Terheyden Patrick

СтатьяПеревод в очереди

Аннотация

OBJECTIVES

Merkel cell carcinoma (MCC) is a rare, highly aggressive neuroendocrine skin cancer, which typically affects elderly and immunocompromised and/or immunosuppressed patients. The checkpoint inhibitor avelumab, a mAb targeting the anti-programmed cell death ligand 1 (anti-PD-L1), has revolutionized the treatment of metastatic MCC, achieving dramatic improvements in disease control and overall survival. However, checkpoint inhibitors are associated with the development of immune-related adverse events, such as exacerbation of pre-existing RA. Although most immune-related adverse events can be managed successfully with CSs, their frequent and/or long-term use runs the risk of undermining the efficacy of immune checkpoint inhibition.

METHODS

We report two cases of MCC, in which immunosuppressive therapy for the management of RA was administered.

RESULTS

Immunosuppression for (i) pre-existing and (ii) immune checkpoint inhibitor-exacerbated RA was associated with progression of metastatic MCC.

CONCLUSION

Any decision to initiate immunosuppressive treatment for RA in patients receiving immune checkpoint inhibitor therapy should include careful consideration of the risk of potentially fatal cancer progression and be taken after consultation with the patient's oncologist and rheumatologist. When the immunosuppressive treatment is required, it should be administered for as short a time as possible and under strict clinical and radiological surveillance.

Для цитирования: Klee Gina, Kisch Tobias, Kümpers Christiane, Perner Sven, Schinke Susanne, Zillikens Detlef, Langan Ewan A, Terheyden Patrick. The treatment of Merkel cell carcinoma with immune checkpoint inhibitors: implications for patients with rheumatoid arthritis.. Rheumatology advances in practice. 2021. DOI: 10.1093/rap/rkab037.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.